Targeted BRAF /MEK inhibition as a salvage therapy for patients with metastatic melanoma harboring a BRAF L597R mutation: two case reports and review of the literature - Andrew Moufarrej; Sarah Biermann; Robin Springer; Norman-Philipp Hoff; Bernhard Homey; Harm-Henning Lindhof (Melanoma Research, 2026)